U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Inactive Ingredients in Approved Drug Products Search

Inactive Ingredient Search for Approved Drug Products

About this Database | Back to Search Page

Guidances | CFR

Search Names Beginning with b

Inactive Ingredient Route Dosage Form CAS Number UNII Maximum Potency per unit dose Maximum Daily Exposure (MDE) Record Updated
BALSAM PERU RECTAL SUPPOSITORY 8007009 8P5F881OCY 100mg
BARIUM SULFATE INTRAUTERINE SUPPOSITORY, EXTENDED RELEASE 7727437 25BB7EKE2E 10mg
BARIUM SULFATE SUBCUTANEOUS IMPLANT 7727437 25BB7EKE2E 15mg
BEEF TALLOW ORAL CAPSULE, EXTENDED RELEASE 61789977 98HPY76U4W 12.4mg
BENTONITE DENTAL POWDER, DENTIFRICE 1302789 A3N5ZCN45C 0.05mg/mg
BENTONITE ORAL CAPSULE 1302789 A3N5ZCN45C ADJ PH
BENTONITE ORAL SUSPENSION 1302789 A3N5ZCN45C 65mg/5ml
BENTONITE ORAL TABLET 1302789 A3N5ZCN45C 355mg
BENTONITE ORAL TABLET, COATED 1302789 A3N5ZCN45C 1.8mg
BENTONITE TOPICAL CREAM 1302789 A3N5ZCN45C 4.1%w/w
BENTONITE TOPICAL LOTION 1302789 A3N5ZCN45C 5%w/w
BENTONITE TOPICAL POWDER 1302789 A3N5ZCN45C 0.67mg/mg
BENTONITE TOPICAL SHAMPOO, SUSPENSION 1302789 A3N5ZCN45C 3.25%w/v
BENTONITE TRANSDERMAL SYSTEM 1302789 A3N5ZCN45C 9.86mg
BENTONITE VAGINAL SUPPOSITORY 1302789 A3N5ZCN45C 288.1mg
BENZALDEHYDE ORAL LOZENGE 100527 TA269SD04T 31mg
BENZALDEHYDE ORAL SUSPENSION 100527 TA269SD04T 0.6mg/1ml
BENZALKONIUM CHLORIDE AURICULAR (OTIC) SOLUTION 8001545 F5UM2KM3W7 NA
BENZALKONIUM CHLORIDE AURICULAR (OTIC) SUSPENSION 8001545 F5UM2KM3W7 0.01%w/v
BENZALKONIUM CHLORIDE INTRA-ARTICULAR INJECTION 8001545 F5UM2KM3W7 1mg
BENZALKONIUM CHLORIDE INTRALESIONAL INJECTION 8001545 F5UM2KM3W7 1mg
BENZALKONIUM CHLORIDE INTRAMUSCULAR INJECTION 8001545 F5UM2KM3W7 1mg
BENZALKONIUM CHLORIDE NASAL LIQUID 8001545 F5UM2KM3W7 0.2mg/1ml
BENZALKONIUM CHLORIDE NASAL SOLUTION 8001545 F5UM2KM3W7 40.46mg/100ml
BENZALKONIUM CHLORIDE NASAL SPRAY 8001545 F5UM2KM3W7 1mg
BENZALKONIUM CHLORIDE NASAL SPRAY, METERED 8001545 F5UM2KM3W7 0.7mg/1ml
BENZALKONIUM CHLORIDE OPHTHALMIC GEL 8001545 F5UM2KM3W7 0.01%w/w
BENZALKONIUM CHLORIDE OPHTHALMIC SOLUTION 8001545 F5UM2KM3W7 2%w/v
BENZALKONIUM CHLORIDE OPHTHALMIC SOLUTION/ DROPS 8001545 F5UM2KM3W7 0.03%w/v
BENZALKONIUM CHLORIDE OPHTHALMIC SUSPENSION 8001545 F5UM2KM3W7 0.02%w/v
BENZALKONIUM CHLORIDE OPHTHALMIC SUSPENSION/ DROPS 8001545 F5UM2KM3W7 0.02%w/v
BENZALKONIUM CHLORIDE RESPIRATORY (INHALATION) SOLUTION 8001545 F5UM2KM3W7 0.02%w/w
BENZALKONIUM CHLORIDE TOPICAL CLOTH 8001545 F5UM2KM3W7 NA
BENZALKONIUM CHLORIDE TOPICAL LOTION 8001545 F5UM2KM3W7 0.1%w/w
BENZALKONIUM CHLORIDE TOPICAL OINTMENT 8001545 F5UM2KM3W7 0.03%w/w
BENZALKONIUM CHLORIDE TOPICAL SHAMPOO 8001545 F5UM2KM3W7 0.2%w/w
BENZALKONIUM CHLORIDE TOPICAL SOLUTION 8001545 F5UM2KM3W7 0.02%w/v
BENZALKONIUM CHLORIDE TOPICAL SOLUTION/ DROPS 8001545 F5UM2KM3W7 0.01%w/v
BENZALKONIUM CHLORIDE TOPICAL SUSPENSION/ DROPS 8001545 F5UM2KM3W7 NA
BENZENESULFONIC ACID INTRAVENOUS INJECTION 98113 685928Z18A ADJ PH
BENZENESULFONIC ACID INTRAVENOUS INJECTION, SOLUTION 98113 685928Z18A ADJ PH
BENZENESULFONIC ACID INTRAVENOUS LIQUID 98113 685928Z18A ADJ PH
BENZETHONIUM CHLORIDE AURICULAR (OTIC) SOLUTION 121540 PH41D05744 0.02%w/v
BENZETHONIUM CHLORIDE INTRAMUSCULAR INJECTION 121540 PH41D05744 1mg
BENZETHONIUM CHLORIDE INTRAVENOUS INJECTION 121540 PH41D05744 1mg
BENZETHONIUM CHLORIDE INTRAVENOUS INJECTION, POWDER, FOR SOLUTION 121540 PH41D05744 0.5mg
BENZETHONIUM CHLORIDE OPHTHALMIC SOLUTION/ DROPS 121540 PH41D05744 0.02%w/w
BENZETHONIUM CHLORIDE TOPICAL CREAM 121540 PH41D05744 NA
BENZOCAINE TOPICAL OINTMENT 94097 U3RSY48JW5 1%w/w
BENZODODECINIUM BROMIDE OPHTHALMIC SOLUTION, GEL FORMING, EXTENDED RELEASE 7281041 IRY12B2TQ6 0.01%w/w
BENZOIC ACID BUCCAL MOUTHWASH 65850 8SKN0B0MIM NA
BENZOIC ACID INTRAMUSCULAR INJECTION 65850 8SKN0B0MIM 5%w/v
BENZOIC ACID INTRAMUSCULAR INJECTION, SOLUTION 65850 8SKN0B0MIM 0.2%w/v
BENZOIC ACID INTRAVENOUS INJECTION 65850 8SKN0B0MIM 5%w/v
BENZOIC ACID IRRIGATION SOLUTION 65850 8SKN0B0MIM 0.02%w/v
BENZOIC ACID ORAL CONCENTRATE 65850 8SKN0B0MIM 12.5mg/5ml
BENZOIC ACID ORAL ELIXIR 65850 8SKN0B0MIM 90mg
BENZOIC ACID ORAL LIQUID 65850 8SKN0B0MIM 2mg/1ml
BENZOIC ACID ORAL SOLUTION 65850 8SKN0B0MIM 100mg
BENZOIC ACID ORAL SUSPENSION 65850 8SKN0B0MIM 15mg
BENZOIC ACID ORAL SYRUP 65850 8SKN0B0MIM 20mg
BENZOIC ACID ORAL TABLET, COATED 65850 8SKN0B0MIM NA
BENZOIC ACID ORAL TABLET, FILM COATED 65850 8SKN0B0MIM NA
BENZOIC ACID RECTAL GEL 65850 8SKN0B0MIM 11mg
BENZOIC ACID RECTAL SUSPENSION 65850 8SKN0B0MIM 0.1%w/w
BENZOIC ACID TOPICAL AEROSOL, FOAM 65850 8SKN0B0MIM 1mg
BENZOIC ACID TOPICAL CREAM 65850 8SKN0B0MIM 6mg Y
BENZOIC ACID TOPICAL GEL 65850 8SKN0B0MIM 0.1%w/w
BENZOIC ACID TOPICAL LOTION 65850 8SKN0B0MIM 0.2%w/w
BENZOIC ACID TOPICAL SOLUTION 65850 8SKN0B0MIM 0.1%w/w
BENZOIC ACID VAGINAL AEROSOL, FOAM 65850 8SKN0B0MIM 0.1%w/w
BENZOIC ACID VAGINAL CREAM 65850 8SKN0B0MIM 0.25%w/w
BENZOIC ACID VAGINAL SUPPOSITORY 65850 8SKN0B0MIM 2mg
BENZOIN RESIN TOPICAL OINTMENT 9000059 GK21SBA74R NA
BENZOIN, (+/-)- ORAL CAPSULE 119539 L7J6A1NE81 NA
BENZOIN, (+/-)- ORAL CAPSULE, EXTENDED RELEASE 119539 L7J6A1NE81 NA
BENZYL ALCOHOL AURICULAR (OTIC) SUSPENSION 100516 LKG8494WBH 0.9%w/v
BENZYL ALCOHOL ENDOTRACHEAL INJECTION 100516 LKG8494WBH 54mg
BENZYL ALCOHOL EPIDURAL INJECTION 100516 LKG8494WBH 1%w/v
BENZYL ALCOHOL INTRA-ARTERIAL INJECTION 100516 LKG8494WBH 0.9%w/v
BENZYL ALCOHOL INTRA-ARTICULAR INJECTION 100516 LKG8494WBH 40mg
BENZYL ALCOHOL INTRA-ARTICULAR INJECTION, SOLUTION 100516 LKG8494WBH 23mg
BENZYL ALCOHOL INTRA-ARTICULAR INJECTION, SUSPENSION 100516 LKG8494WBH 40mg
BENZYL ALCOHOL INTRABURSAL INJECTION 100516 LKG8494WBH 1%w/v
BENZYL ALCOHOL INTRACAVITARY INJECTION 100516 LKG8494WBH 0.01ml
BENZYL ALCOHOL INTRACAVITARY INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 100516 LKG8494WBH 8.4mg
BENZYL ALCOHOL INTRALESIONAL INJECTION 100516 LKG8494WBH 18mg
BENZYL ALCOHOL INTRALESIONAL INJECTION, SUSPENSION 100516 LKG8494WBH 18mg
BENZYL ALCOHOL INTRAMUSCULAR INJECTION 100516 LKG8494WBH 1000mg
BENZYL ALCOHOL INTRAMUSCULAR INJECTION, EMULSION 100516 LKG8494WBH 225mg
BENZYL ALCOHOL INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION 100516 LKG8494WBH 144mg
BENZYL ALCOHOL INTRAMUSCULAR INJECTION, SOLUTION 100516 LKG8494WBH 500mg
BENZYL ALCOHOL INTRAMUSCULAR INJECTION, SUSPENSION 100516 LKG8494WBH 40mg
BENZYL ALCOHOL INTRAMUSCULAR SOLUTION 100516 LKG8494WBH 20mg
BENZYL ALCOHOL INTRASYNOVIAL INJECTION, SUSPENSION 100516 LKG8494WBH 18mg Y
BENZYL ALCOHOL INTRAVENOUS INJECTION 100516 LKG8494WBH 1620mg
BENZYL ALCOHOL INTRAVENOUS INJECTION, EMULSION 100516 LKG8494WBH 45mg
BENZYL ALCOHOL INTRAVENOUS INJECTION, POWDER, FOR SOLUTION 100516 LKG8494WBH 144mg
BENZYL ALCOHOL INTRAVENOUS INJECTION, SOLUTION 100516 LKG8494WBH 400mg
BENZYL ALCOHOL INTRAVENOUS LIQUID 100516 LKG8494WBH 1.04%w/v
BENZYL ALCOHOL INTRAVENOUS SOLUTION 100516 LKG8494WBH 242mg
BENZYL ALCOHOL NASAL SPRAY 100516 LKG8494WBH 5mg Y
BENZYL ALCOHOL NASAL SPRAY, METERED 100516 LKG8494WBH 5mg/1ml
BENZYL ALCOHOL ORAL CAPSULE 100516 LKG8494WBH 450mg
BENZYL ALCOHOL ORAL CAPSULE, EXTENDED RELEASE 100516 LKG8494WBH 1.23mg
BENZYL ALCOHOL ORAL SOLUTION 100516 LKG8494WBH 50mg/1ml
BENZYL ALCOHOL ORAL SUSPENSION 100516 LKG8494WBH 100mg
BENZYL ALCOHOL ORAL TABLET 100516 LKG8494WBH 1.06mg
BENZYL ALCOHOL ORAL TABLET, DELAYED RELEASE 100516 LKG8494WBH 2.31mg
BENZYL ALCOHOL ORAL TABLET, FILM COATED, EXTENDED RELEASE 100516 LKG8494WBH 1.25mg
BENZYL ALCOHOL RECTAL GEL 100516 LKG8494WBH 124mg
BENZYL ALCOHOL RECTAL SUPPOSITORY 100516 LKG8494WBH 129mg
BENZYL ALCOHOL SOFT TISSUE INJECTION 100516 LKG8494WBH 18mg
BENZYL ALCOHOL SOFT TISSUE INJECTION, SUSPENSION 100516 LKG8494WBH 40mg
BENZYL ALCOHOL SUBCONJUNCTIVAL INJECTION 100516 LKG8494WBH 252mg
BENZYL ALCOHOL SUBCUTANEOUS INJECTION 100516 LKG8494WBH 90mg
BENZYL ALCOHOL SUBCUTANEOUS INJECTION, EMULSION 100516 LKG8494WBH 225mg
BENZYL ALCOHOL SUBCUTANEOUS INJECTION, SOLUTION 100516 LKG8494WBH 0.95%w/v
BENZYL ALCOHOL TOPICAL CREAM 100516 LKG8494WBH 160mg
BENZYL ALCOHOL TOPICAL CREAM, AUGMENTED 100516 LKG8494WBH 1%w/w
BENZYL ALCOHOL TOPICAL GEL 100516 LKG8494WBH 185mg
BENZYL ALCOHOL TOPICAL LOTION 100516 LKG8494WBH 2%w/w
BENZYL ALCOHOL TOPICAL OINTMENT 100516 LKG8494WBH 2.2%w/w
BENZYL ALCOHOL TOPICAL SHAMPOO 100516 LKG8494WBH 1.25%w/w
BENZYL ALCOHOL TOPICAL SOLUTION 100516 LKG8494WBH 2%w/w
BENZYL ALCOHOL TOPICAL SUSPENSION 100516 LKG8494WBH 1%w/w
BENZYL ALCOHOL VAGINAL CREAM 100516 LKG8494WBH 1%w/w
BENZYL ALCOHOL VAGINAL SUPPOSITORY 100516 LKG8494WBH NA
BENZYL BENZOATE INTRAMUSCULAR INJECTION 120514 N863NB338G 1500mg
BENZYL BENZOATE INTRAMUSCULAR INJECTION, SOLUTION 120514 N863NB338G 750mg
BENZYL BENZOATE INTRAMUSCULAR SOLUTION 120514 N863NB338G 447mg
BENZYL BENZOATE ORAL CAPSULE 120514 N863NB338G NA
BENZYL CHLORIDE INTRAVENOUS INJECTION 100447 83H19HW7K6 NA
BETA CAROTENE ORAL EMULSION 7235407 01YAE03M7J NA
BETA CAROTENE TOPICAL CREAM 7235407 01YAE03M7J NA
BETADEX ORAL TABLET 7585399 JV039JZZ3A 133.33mg
BETADEX ORAL TABLET, CHEWABLE 7585399 JV039JZZ3A 85mg
BETADEX ORAL TABLET, FILM COATED 7585399 JV039JZZ3A 41.25mg
BETADEX TOPICAL GEL 7585399 JV039JZZ3A 20mg
BETADEX SULFOBUTYL ETHER SODIUM INTRAMUSCULAR INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 182410000 2PP9364507 883mg
BETADEX SULFOBUTYL ETHER SODIUM INTRAVENOUS INJECTION 182410000 2PP9364507 6574mg
BETADEX SULFOBUTYL ETHER SODIUM INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 182410000 2PP9364507 19200mg
BETADEX SULFOBUTYL ETHER SODIUM INTRAVENOUS INJECTION, SOLUTION 182410000 2PP9364507 13333mg
BETANAPHTHOL ORAL CAPSULE 135193 P2Z71CIK5H 0.3mg
BISMUTH SUBCARBONATE ORAL TABLET 5892104 M41L2IN55T 4.35mg
BISMUTH SUBCARBONATE ORAL TABLET, EXTENDED RELEASE 5892104 M41L2IN55T 0.04mg
BLACK CURRANT ORAL SOLUTION 9755T40D11 213mg
BLACK INK ORAL CAPSULE NA 1mg
BLACK INK ORAL CAPSULE, DELAYED RELEASE NA 0.57mg
BLACK INK ORAL CAPSULE, EXTENDED RELEASE NA 0.03mg
BLACK INK ORAL CAPSULE, LIQUID FILLED NA NA
BLACK INK ORAL TABLET NA 0.14mg
BLACK INK ORAL TABLET, DELAYED RELEASE NA 1mg
BLACK INK ORAL TABLET, EXTENDED RELEASE NA 3mg
BLACK INK ORAL TABLET, FILM COATED NA 0.15mg
BLACK INK ORAL TABLET, FILM COATED, EXTENDED RELEASE NA NA
BLACK INK RESPIRATORY (INHALATION) CAPSULE NA NA
BLACK INK RESPIRATORY (INHALATION) POWDER NA NA
BORIC ACID AURICULAR (OTIC) SOLUTION 10043353 R57ZHV85D4 0.05%w/w
BORIC ACID AURICULAR (OTIC) SUSPENSION 10043353 R57ZHV85D4 0.6%w/v
BORIC ACID BUCCAL MOUTHWASH 10043353 R57ZHV85D4 7.36mg/1ml
BORIC ACID INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 10043353 R57ZHV85D4 0.53%w/v
BORIC ACID INTRAVENOUS INJECTION, SOLUTION 10043353 R57ZHV85D4 0.32%w/v
BORIC ACID OPHTHALMIC DROPS 10043353 R57ZHV85D4 1%w/w
BORIC ACID OPHTHALMIC EMULSION 10043353 R57ZHV85D4 0.3%w/v
BORIC ACID OPHTHALMIC GEL 10043353 R57ZHV85D4 0.5%w/w
BORIC ACID OPHTHALMIC SOLUTION 10043353 R57ZHV85D4 38mg
BORIC ACID OPHTHALMIC SOLUTION, GEL FORMING, EXTENDED RELEASE 10043353 R57ZHV85D4 0.3%w/w
BORIC ACID OPHTHALMIC SOLUTION/ DROPS 10043353 R57ZHV85D4 48mg
BORIC ACID OPHTHALMIC SUSPENSION 10043353 R57ZHV85D4 0.3%w/v
BORIC ACID OPHTHALMIC SUSPENSION/ DROPS 10043353 R57ZHV85D4 1%w/v Y
BORIC ACID TOPICAL EMULSION 10043353 R57ZHV85D4 1.3%w/w
BORIC ACID TOPICAL SHAMPOO 10043353 R57ZHV85D4 2%w/w
BORIC ACID TOPICAL SOLUTION 10043353 R57ZHV85D4 1.24%w/v
BORIC ACID TOPICAL SUSPENSION/ DROPS 10043353 R57ZHV85D4 0.3%w/v
BORIC ACID VAGINAL JELLY 10043353 R57ZHV85D4 1%w/w
BROWN IRON OXIDE ORAL CAPSULE 52357707 1N032N7MFO NA
BROWN IRON OXIDE ORAL TABLET 52357707 1N032N7MFO 0.79mg
BROWN IRON OXIDE ORAL TABLET, FILM COATED 52357707 1N032N7MFO 0.2mg
BUTANE RECTAL AEROSOL, FOAM 106978 6LV4FOR43R 12mg
BUTANE TOPICAL AEROSOL 106978 6LV4FOR43R NA
BUTANE TOPICAL AEROSOL, FOAM 106978 6LV4FOR43R 27%w/w
BUTYL ALCOHOL ORAL CAPSULE 71363 8PJ61P6TS3 0.02mg
BUTYL ALCOHOL ORAL CAPSULE, COATED, EXTENDED RELEASE 71363 8PJ61P6TS3 NA
BUTYL ALCOHOL ORAL CAPSULE, EXTENDED RELEASE 71363 8PJ61P6TS3 0.01mg
BUTYL ALCOHOL ORAL TABLET 71363 8PJ61P6TS3 0.01mg
BUTYL ALCOHOL ORAL TABLET, COATED 71363 8PJ61P6TS3 NA
BUTYL ALCOHOL ORAL TABLET, DELAYED RELEASE 71363 8PJ61P6TS3 0.05mg
BUTYL ALCOHOL ORAL TABLET, EXTENDED RELEASE 71363 8PJ61P6TS3 NA
BUTYL ALCOHOL TOPICAL SOLUTION 71363 8PJ61P6TS3 0.08%w/w
BUTYL ALCOHOL TOPICAL SWAB 71363 8PJ61P6TS3 0.08%w/w
BUTYL ESTER OF METHYL VINYL ETHER/MALEIC ANHYDRIDE COPOLYMER (125000 MW) TOPICAL SOLUTION 25119680 389H2R62BD 15%w/w
BUTYL METHACRYLATE AND METHYL METHACRYLATE COPOLYMER (3:1; 150000 MW) TRANSDERMAL SYSTEM 25608337 DJN2FGG8Z3 18mg
BUTYL STEARATE TOPICAL CREAM 123955 6Y0AI5605C 3.68%w/w
BUTYL STEARATE TOPICAL LOTION 123955 6Y0AI5605C NA
BUTYLATED HYDROXYANISOLE INTRAVENOUS INJECTION 25013165 REK4960K2U NA
BUTYLATED HYDROXYANISOLE INTRAVENOUS INJECTION, POWDER, FOR SOLUTION 25013165 REK4960K2U NA
BUTYLATED HYDROXYANISOLE INTRAVENOUS INJECTION, SOLUTION 25013165 REK4960K2U NA
BUTYLATED HYDROXYANISOLE NASAL SOLUTION 25013165 REK4960K2U 20mg/100ml
BUTYLATED HYDROXYANISOLE ORAL CAPSULE 25013165 REK4960K2U 4mg
BUTYLATED HYDROXYANISOLE ORAL CAPSULE, GELATIN COATED 25013165 REK4960K2U 0.07mg
BUTYLATED HYDROXYANISOLE ORAL CAPSULE, LIQUID FILLED 25013165 REK4960K2U 4mg
BUTYLATED HYDROXYANISOLE ORAL CONCENTRATE 25013165 REK4960K2U 0.08mg/1ml
BUTYLATED HYDROXYANISOLE ORAL GRANULE, FOR SUSPENSION 25013165 REK4960K2U NA
BUTYLATED HYDROXYANISOLE ORAL LIQUID 25013165 REK4960K2U 8mg
BUTYLATED HYDROXYANISOLE ORAL SOLUTION 25013165 REK4960K2U 5mg
BUTYLATED HYDROXYANISOLE ORAL SUSPENSION 25013165 REK4960K2U 2.5mg/5ml
BUTYLATED HYDROXYANISOLE ORAL SYRUP 25013165 REK4960K2U 0.5mg/5ml
BUTYLATED HYDROXYANISOLE ORAL TABLET 25013165 REK4960K2U 8mg
BUTYLATED HYDROXYANISOLE ORAL TABLET, EXTENDED RELEASE 25013165 REK4960K2U 1mg
BUTYLATED HYDROXYANISOLE ORAL TABLET, FILM COATED 25013165 REK4960K2U 0.4mg
BUTYLATED HYDROXYANISOLE ORAL TABLET, ORALLY DISINTEGRATING 25013165 REK4960K2U 2mg
BUTYLATED HYDROXYANISOLE RECTAL SUPPOSITORY 25013165 REK4960K2U 0.21mg
BUTYLATED HYDROXYANISOLE SUBLINGUAL FILM 25013165 REK4960K2U 0.08mg
BUTYLATED HYDROXYANISOLE SUBLINGUAL TABLET 25013165 REK4960K2U 2mg
BUTYLATED HYDROXYANISOLE TOPICAL CREAM 25013165 REK4960K2U 5.2%w/w
BUTYLATED HYDROXYANISOLE TOPICAL GEL 25013165 REK4960K2U 7mg
BUTYLATED HYDROXYANISOLE TOPICAL LOTION 25013165 REK4960K2U NA
BUTYLATED HYDROXYANISOLE TOPICAL OINTMENT 25013165 REK4960K2U 0.01%w/w
BUTYLATED HYDROXYANISOLE VAGINAL CREAM 25013165 REK4960K2U 0.03%w/w
BUTYLATED HYDROXYANISOLE VAGINAL OINTMENT 25013165 REK4960K2U 0.02%w/w
BUTYLATED HYDROXYANISOLE VAGINAL SUPPOSITORY 25013165 REK4960K2U 1mg
BUTYLATED HYDROXYTOLUENE BUCCAL GUM, CHEWING 128370 1P9D0Z171K 5mg
BUTYLATED HYDROXYTOLUENE INTRAVENOUS INJECTION 128370 1P9D0Z171K NA
BUTYLATED HYDROXYTOLUENE INTRAVENOUS INJECTION, POWDER, FOR SOLUTION 128370 1P9D0Z171K NA
BUTYLATED HYDROXYTOLUENE INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 128370 1P9D0Z171K 0.02mg
BUTYLATED HYDROXYTOLUENE INTRAVENOUS INJECTION, SOLUTION 128370 1P9D0Z171K NA
BUTYLATED HYDROXYTOLUENE NASAL SPRAY, METERED 128370 1P9D0Z171K 0.1mg/1ml
BUTYLATED HYDROXYTOLUENE ORAL CAPSULE 128370 1P9D0Z171K 1mg
BUTYLATED HYDROXYTOLUENE ORAL CAPSULE, LIQUID FILLED 128370 1P9D0Z171K 0.1mg
BUTYLATED HYDROXYTOLUENE ORAL FILM, SOLUBLE 128370 1P9D0Z171K 0.06mg
BUTYLATED HYDROXYTOLUENE ORAL SOLUTION 128370 1P9D0Z171K 0.19mg/1ml
BUTYLATED HYDROXYTOLUENE ORAL SOLUTION, CONCENTRATE 128370 1P9D0Z171K 0.1mg/1ml
BUTYLATED HYDROXYTOLUENE ORAL TABLET 128370 1P9D0Z171K 3mg
BUTYLATED HYDROXYTOLUENE ORAL TABLET, EXTENDED RELEASE 128370 1P9D0Z171K 1mg
BUTYLATED HYDROXYTOLUENE ORAL TABLET, FILM COATED 128370 1P9D0Z171K 1mg
BUTYLATED HYDROXYTOLUENE ORAL TABLET, FILM COATED, EXTENDED RELEASE 128370 1P9D0Z171K 0.24mg
BUTYLATED HYDROXYTOLUENE ORAL TABLET, FOR SUSPENSION 128370 1P9D0Z171K 0.1mg
BUTYLATED HYDROXYTOLUENE ORAL TABLET, ORALLY DISINTEGRATING 128370 1P9D0Z171K 1mg
BUTYLATED HYDROXYTOLUENE RECTAL SUPPOSITORY 128370 1P9D0Z171K 0.21mg
BUTYLATED HYDROXYTOLUENE SUBLINGUAL TABLET 128370 1P9D0Z171K 0.13mg
BUTYLATED HYDROXYTOLUENE TOPICAL AEROSOL 128370 1P9D0Z171K 0.1%w/w
BUTYLATED HYDROXYTOLUENE TOPICAL AEROSOL, FOAM 128370 1P9D0Z171K 0.1%w/w
BUTYLATED HYDROXYTOLUENE TOPICAL CREAM 128370 1P9D0Z171K 1mg
BUTYLATED HYDROXYTOLUENE TOPICAL CREAM, AUGMENTED 128370 1P9D0Z171K 0.2%w/w
BUTYLATED HYDROXYTOLUENE TOPICAL GEL 128370 1P9D0Z171K 8mg
BUTYLATED HYDROXYTOLUENE TOPICAL GEL, METERED 128370 1P9D0Z171K 4mg
BUTYLATED HYDROXYTOLUENE TOPICAL LOTION 128370 1P9D0Z171K 0.5%w/w
BUTYLATED HYDROXYTOLUENE TOPICAL OINTMENT 128370 1P9D0Z171K 0.1%w/w
BUTYLATED HYDROXYTOLUENE TOPICAL SHAMPOO 128370 1P9D0Z171K 0.1%w/w
BUTYLATED HYDROXYTOLUENE TOPICAL SOAP 128370 1P9D0Z171K 0.02%w/w
BUTYLATED HYDROXYTOLUENE TOPICAL SOLUTION 128370 1P9D0Z171K 0.09%w/v
BUTYLATED HYDROXYTOLUENE TOPICAL SPRAY 128370 1P9D0Z171K 3mg
BUTYLATED HYDROXYTOLUENE TOPICAL SUSPENSION 128370 1P9D0Z171K 0.02%w/w
BUTYLATED HYDROXYTOLUENE TOPICAL SWAB 128370 1P9D0Z171K 0.5%w/w
BUTYLATED HYDROXYTOLUENE TRANSDERMAL GEL 128370 1P9D0Z171K 0.05%w/w
BUTYLATED HYDROXYTOLUENE VAGINAL CREAM 128370 1P9D0Z171K 0.05%w/w
BUTYLATED HYDROXYTOLUENE VAGINAL SUPPOSITORY 128370 1P9D0Z171K NA
BUTYLENE GLYCOL TOPICAL SYSTEM 107880 3XUS85K0RA 1400mg
BUTYLENE GLYCOL TRANSDERMAL SYSTEM 107880 3XUS85K0RA 8.12mg
BUTYLPARABEN OPHTHALMIC SOLUTION 94268 3QPI1U3FV8 0.02%w/w
BUTYLPARABEN ORAL CAPSULE 94268 3QPI1U3FV8 NA
BUTYLPARABEN ORAL CAPSULE, EXTENDED RELEASE 94268 3QPI1U3FV8 NA
BUTYLPARABEN ORAL DROPS 94268 3QPI1U3FV8 NA
BUTYLPARABEN ORAL SOLUTION 94268 3QPI1U3FV8 6mg
BUTYLPARABEN ORAL SUSPENSION 94268 3QPI1U3FV8 12mg
BUTYLPARABEN ORAL SYRUP 94268 3QPI1U3FV8 28.4mg/1ml
BUTYLPARABEN ORAL TABLET 94268 3QPI1U3FV8 NA
BUTYLPARABEN ORAL TABLET, COATED 94268 3QPI1U3FV8 0.08mg
BUTYLPARABEN ORAL TABLET, EXTENDED RELEASE 94268 3QPI1U3FV8 0.01mg
BUTYLPARABEN ORAL TABLET, FILM COATED, EXTENDED RELEASE 94268 3QPI1U3FV8 NA
BUTYLPARABEN RECTAL SOLUTION 94268 3QPI1U3FV8 0.01%w/v
BUTYLPARABEN TOPICAL CREAM 94268 3QPI1U3FV8 0.4%w/w
BUTYLPARABEN TOPICAL LIQUID 94268 3QPI1U3FV8 0.02%w/w
BUTYLPARABEN TOPICAL LOTION 94268 3QPI1U3FV8 4mg
BUTYLPARABEN TOPICAL OINTMENT 94268 3QPI1U3FV8 0.18%w/w

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: January 5, 2024
Database Last Updated: January 26, 2024

Back to Top